Treatment of CML mice with Zileuton, an Alox5 enzymatic activity inhibitor, depleted murine CML stem cells and prolonged the survival of CML mice [51]. The gene discussed is ALOX5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.